Andrew Wasson

Adjunct Professor of Law

Andrew Wasson is a partner in the New York office of Haug Partners and is the chair of the firm’s FDA practice.  Andrew’s practice primarily involves representing life science companies on issues at the intersection of patent law, FDA regulatory law, and antitrust law. 

Having a master's degree in philosophy, as well as an undergraduate degree in biology, Andrew is especially interested in exploring touchpoints between law and the philosophies of science, technology, and medicine. Andrew serves on the editorial advisory board of the Food and Drug Law Journal.